Article metrics

Download PDFPDF

Original research
Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy

 

Online download statistics by month:

Online download statistics by month: December 2020 to July 2022

AbstractFullPdf
Dec 2020454415
Jan 2021444438169
Feb 202116716134
Mar 202112411954
Apr 2021838020
May 202110210223
Jun 2021969421
Jul 20211019534
Aug 2021747019
Sep 202111510949
Oct 2021948952
Nov 2021444144
Dec 2021676439
Jan 2022555220
Feb 2022464423
Mar 2022666026
Apr 2022828025
May 2022727130
Jun 2022777529
Jul 2022414331
Total19951931757